PremiaLab HK Limited announced that it has received $220 million in a round of funding on December 16, 2025. The transaction included participation from new investors, KKR Next Generation Technology Growth Fund III SCSp, a fund managed by KKR & Co. Inc., and returning investor, Balderton Capital (UK) LLP.

The fund raised through convertible preferred stock.